Everand Logo

Welcome to Everand!

  • STAT

    In encouraging sign, Ebola vaccine appears to provide long-lasting protection

    by Helen Branswell Apr 16, 2018 3 minutes
    A woman receives an Ebola vaccination in 2015 at a health center in Conakry, Guinea.

    An international consortium of researchers has reported that an Ebola vaccine appears to provide volunteers protection against the virus two years after they were injected —  encouraging findings both for the public health community and the vaccine’s manufacturer.

    An , conducted in Guinea near the end of the devastating , showed the vaccine from Merck, which is given in a single shot, rapidly generated protection against the virus. But how long that protection lasts remained

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
    An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
    MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

    Related